County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries

BACKGROUND: Cardioprotective antihyperglycemic agents, SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP1RA), improve outcomes of patients with type 2 diabetes, but adoption has been limited. Differences across individuals have been noted but area-level variation is unknown. OBJECTIVES: Giv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Jonathan, Nargesi, Arash A, Essien, Utibe R., Sangha, Veer, Lin, Zhenqiu, Krumholz, Harlan M, Khera, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364091/
https://www.ncbi.nlm.nih.gov/pubmed/35968531
http://dx.doi.org/10.1016/j.ajpc.2022.100370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364091/
https://www.ncbi.nlm.nih.gov/pubmed/35968531
http://dx.doi.org/10.1016/j.ajpc.2022.100370

Ejemplares similares